Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
90.27
-0.53 (-0.59%)
Aug 17, 2026, 9:30 AM EDT - Market open

Haemonetics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
4,1072,5113,1754,3354,1753,263
Market Cap Growth
58.21%-20.89%-26.76%3.83%27.92%-42.69%
Enterprise Value
5,0563,3734,1455,0114,7173,809
Last Close Price
90.8054.0463.1985.3582.7563.85
PE Ratio
43.8425.8118.9336.8736.1775.24
Forward PE
16.6710.4613.2120.4925.4523.82
PS Ratio
3.061.882.333.313.573.29
PB Ratio
4.933.153.874.515.104.36
P/TBV Ratio
----54.93-
P/FCF Ratio
14.199.6422.2930.1851.0843.08
P/OCF Ratio
12.598.5717.4723.8515.2918.95
PEG Ratio
1.550.961.001.392.421.36
EV/Sales Ratio
3.762.533.053.834.043.84
EV/EBITDA Ratio
14.169.4411.6517.0418.7219.87
EV/EBIT Ratio
19.9413.4116.7824.3828.2136.22
EV/FCF Ratio
17.4512.9529.1034.8957.7150.28
Debt / Equity Ratio
1.401.601.560.911.021.12
Debt / EBITDA Ratio
3.183.473.492.873.284.14
Debt / FCF Ratio
4.034.899.016.0810.1611.07
Net Debt / Equity Ratio
1.131.291.190.720.670.77
Net Debt / EBITDA Ratio
2.652.882.742.362.163.02
Net Debt / FCF Ratio
3.263.956.854.836.677.64
Asset Turnover
0.560.550.590.630.620.54
Inventory Turnover
1.651.611.712.081.981.50
Quick Ratio
1.671.640.881.291.850.95
Current Ratio
3.082.951.622.563.061.71
Return on Equity (ROE)
11.20%12.03%18.83%13.22%14.72%5.86%
Return on Assets (ROA)
6.60%6.49%6.65%6.22%5.51%3.57%
Return on Invested Capital (ROIC)
10.42%10.56%11.33%10.55%10.14%5.40%
Return on Capital Employed (ROCE)
12.10%11.90%13.20%10.80%9.90%7.40%
Earnings Yield
2.33%3.88%5.28%2.71%2.76%1.33%
FCF Yield
7.05%10.37%4.49%3.31%1.96%2.32%
Buyback Yield / Dilution
6.48%6.65%1.30%0.04%-0.13%-0.12%
SEC Filings: 10-K · 10-Q